Spyros Papapetropoulos - 03 May 2022 Form 4 Insider Report for Vigil Neuroscience, Inc. (VIGL)

Role: Chief Medical Officer
Signature: /s/ Jennifer Ziolkowski, Attorney-in-Fact
Issuer symbol: VIGL
Transactions as of: 03 May 2022
Net transactions value: +$13,591
Form type: 4
Filing time: 04 May 2022, 07:00:11 UTC
Previous filing: 12 Apr 2022
Next filing: 10 Jun 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIGL	Common Stock	Purchase	$13,591	+4,000		$3.40	4,000	03 May 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.276 to $3.4059, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.

Content

The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.276 to $3.4059, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.